Zobrazeno 1 - 10
of 396
pro vyhledávání: '"Jennifer S. Temel"'
Autor:
Jamie M Jacobs, Chelsea S Rapoport, Arielle Horenstein, Madison Clay, Emily A Walsh, Jeffrey Peppercorn, Jennifer S Temel, Joseph A Greer
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Introduction Patient adherence to adjuvant endocrine therapy (AET) after a diagnosis of hormone-sensitive breast cancer is poor. Previous interventions have failed to produce changes in adherence, address patient preferences or include theoretically
Externí odkaz:
https://doaj.org/article/f7a49899b9b64926bfbb305f00b343c9
Autor:
Laura A. Petrillo, Areej El-Jawahri, Jennifer S. Temel, Sophia Landay, Ryan D. Nipp, Charn-Xin Fuh, Carolyn L. Qian, Deirdre O'Callaghan, Zhi Ven Fong, Howard J. Lee, Joseph A. Greer, Emilia Kaslow-Zieve, Nneka N. Ufere, Chinenye C. Azoba, Brandon Temel, Lara Traeger
Publikováno v:
JCO Oncology Practice. 18:e313-e324
PURPOSE: Preoperative therapy for pancreatic cancer represents a new treatment option with the potential to improve outcomes for patients, yet with complex risks. By not discussing the potential risks and benefits of new treatment options, clinicians
Autor:
Marie Welsh, Areej El-Jawahri, Kathleen Murphy, Marcin Chwistek, Leigh Kinczewski, Sheila Amrhein, Lauren A Lucas, Jennifer S. Temel, Jessica Bauman, Thomas J. Galloway, Carolyn Y. Fang, Jacqueline Kelly, Florence P Bender, Matthew A Farren, Jessie Panick, John A. Ridge, Brian L. Egleston, Molly E. Collins, Mollie Clark Omilak, Katherine A Schuster
Publikováno v:
J Palliat Med
BACKGROUND: Palliative care improves symptoms and coping in patients with advanced cancers, but has not been evaluated for patients with curable solid malignancies. Because of the tremendous symptom burden and high rates of psychological distress in
Autor:
Joseph A. Greer, Vicki A. Jackson, Emily R. Gallagher, Laura A. Petrillo, Areej El-Jawahri, Jennifer S. Temel
Publikováno v:
J Pain Symptom Manage
Context Targeted therapy has revolutionized lung cancer treatment and markedly increased survival, though data are lacking on patient-reported and end-of-life (EOL) outcomes among patients receiving targeted therapy. Objectives This study aimed to co
Autor:
Justin N. Baker, Jessica Bauman, Finly Zachariah, Leslie A. Fecher, Jennifer Kapo, William Mitchell, Jennifer S. Temel, Jane deLima Thomas, Linda Sutton, Toby C. Campbell, Rajiv Agarwal, Mary Anne Bergman, Jean S. Kutner, Kavitha Ramchandran, Susan McCammon, Melissa L. Teply, Mallory Campbell, Joshua Jones, Danielle J. Doberman, Shalini Dalal, Stephanie Y. Terauchi, Anna C. Beck, Elise C. Carey, Diane Portman, Elizabeth T. Loggers, Amy A. Case, Maria Dans, Ndiya Ogba, Anne Walling, Adeboye Ogunseitan, Richard T. Lee, Andrew S. Epstein
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:780-788
Palliative care has evolved to be an integral part of comprehensive cancer care with the goal of early intervention to improve quality of life and patient outcomes. The NCCN Guidelines for Palliative Care provide recommendations to help the primary o
Autor:
Matthew J. Reynolds, P. Connor Johnson, Alisha M. Yi, Areej El-Jawahri, Ashley M. Nelson, Alison R. Kavanaugh, Jennifer S. Temel, Nora Horick, Carlisle E.W. Topping, Annemarie D. Jagielo, Alyssa L. Fenech, Joseph A. Greer, Vicki A. Jackson
Publikováno v:
Bone Marrow Transplant
An inpatient palliative care intervention during HCT led to improvement in patient QOL and mood. We sought to describe components of the intervention, investigate differences in supportive care practices by treatment arm, and explore whether these di
Autor:
Jennifer S. Temel, Ashley Zhou, Joseph A. Greer, Lara Traeger, Laura A. Petrillo, Robert K. Sommer
Publikováno v:
Journal of Cancer Survivorship. 15:386-391
Molecularly targeted therapies have revolutionized non-small cell lung cancer (NSCLC) treatment. Many patients with metastatic NSCLC receiving targeted therapy may live several years with incurable cancer. We sought to describe how these metastatic c
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Florian J. Fintelmann, Christopher P. Bridge, Jennifer S. Temel, Areej El-Jawahri, J. Peter Marquardt, Eric Roeland, Till D. Best, Michael H. Rosenthal, Chinenye C. Azoba, Nora Horick, Emily E. Van Seventer, Amelie S. Troschel, Joseph A. Greer, Ryan D. Nipp, Richard Newcomb
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:319-327
Background: Low muscle mass (quantity) is common in patients with advanced cancer, but little is known about muscle radiodensity (quality). We sought to describe the associations of muscle mass and radiodensity with symptom burden, healthcare use, an
Autor:
Elyse R. Park, Jennifer S. Temel, Joseph A. Greer, Emily Walsh, Steven A. Safren, Kathryn Post, Amy Comander, Michael H. Antoni, Jeffrey Peppercorn, Chelsea S. Rapoport, Jamie M. Jacobs
Publikováno v:
J Clin Psychol Med Settings
Purpose: Adjuvant endocrine therapy (AET) prevents recurrence after early-stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established;